Results 121 to 130 of about 123,234 (304)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

A Glimpse of Microtransit at an Early Stage: The SmaRT Ride Consumer Market in the Sacramento Area [Policy Brief]

open access: yes
Microtransit is a new, technology-enabled, on-demand transportation mode in which small shuttles provide shared rides through flexible routing and scheduling in response to customers\u2019 requests for rides.
National Center for Sustainable Transportation (NCST)   +2 more
core   +1 more source

Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis

open access: yesMolecular Oncology, EarlyView.
LBR‐driven nuclear fragility supports melanoma invasion. A: Melanocyte presents low LBR (Lamin B Receptor) levels, maintaining nuclear integrity and lamina‐chromatin tethering. B: During malignant progression, upregulation of LBR clusters at the INM (Inner Nuclear Membrane) during confined migration causes local lamina weakening and cholesterol ...
Francesca Lorenzini   +1 more
wiley   +1 more source

We Can Get There From Here: New Perspectives on Transportation Equity [Policy Brief]

open access: yes
This policy brief summarizes findings from the white paper that assesses academic research and transportation planning practice to provide a shared understanding of the definitions, challenges, and opportunities in this field, thereby enabling often ...
Karner, Alex A.   +3 more
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Incorporating Long-Distance Travel into Transportation Planning in the United States [Presentation]

open access: yes
Presentation describing white paper, Incorporating Long-Distance Travel into Transportation Planning in the United States, findings. The white paper suggests utilizing a common framework for long-distance data collection and tabulation that re-defines ...
University of Vermont. Transportation Research Center   +4 more
core  

Identifying Bikeshare Station Locations to Improve Underserved Communities\u2019 Accessibility [Research Brief]

open access: yes
Bikeshare programs are increasingly popular in the United States, and they are an important part of sustainable transportation systems. They offer an alternative mode choice for many types of last-mile trips.
National Center for Sustainable Transportation (NCST)   +3 more
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

open access: yesMolecular Oncology, EarlyView.
Primary brain tumors, whether in adults or children, present a major challenge because of their dramatic prognosis and the ongoing lack of efficient therapeutic approaches. In recent years, a shift has occurred from tumor‐centric concepts to a more holistic view of these tumors as dynamic ecosystems.
Julie Gavard   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy